View Cart (0 items)

Pharmaceutical

Thermo Fisher Scientific to buy Life Technologies Corp. for $13.6 billion

According to Thermo Fisher Scientific, the transaction "will create an unrivaled leader in serving research, speciality diagnostics and applied markets."
Read More

AstraZeneca's asthma treatment drug patent found invalid

Drug manufacturer AstraZeneca has lost a legal battle in the United States after a court ruling that found its patent for a childhood asthma treatment invalid.
Read More

Largest drug companies profited more than $700 billion in decade, analysis estimates

The 11 largest drug companies took $711.4 billion in profits over the 10 years ending in 2012, according to an analysis of corporate filings by Health Care for America Now (HCAN).
Read More

Titan Pharma's opioid dependence treatment recommended for approval

The Psychopharmacologic Drugs Advisory Committee (PDAC) of the U.S. Food and Drug Administration (FDA) has recommended the approval of a new treatment for opioid addiction by Titan Pharmaceuticals, called Probuphine.
Read More

FDA looks into link between diabetes drugs and pancreatic cancer risk

The U.S. Food and Drug Administration (FDA) is investigating a possible link between a number of commonly used diabetes drugs and pre-cancerous changes to the pancreas.
Read More

Bayer confident of business growth with new drugs

German chemical and pharmaceutical giant Bayer has developed an ambitious program that aims to cement the company's position among the leading names in the global pharmaceutical industry.
Read More

Reckitt hit by FDA approval of rival drugs

The U.S. Food and Drug Administration (FDA) has given the green light to two generic versions of Suboxone, a drug used for treating heroin addiction, manufactured by Reckitt Benckiser.
Read More

New drugs launched in UK on the rise

Recent research by a team of scientists at Birmingham University in central England has dismissed fears that British patients might have to cope with a shortage of drugs.
Read More

Merck to pay $8.5 million to settle Vioxx case in Pennsylvania

New Jersey-based pharmaceutical giant Merck & Co. has agreed to pay $8.5 million to the state of Pennsylvania to settle allegations that it inappropriately marketed its painkiller Vioxx.
Read More

Engineer suffers chemical burns at GlaxoSmithKline plant

A 20-year-old engineer suffered chemical burns Tuesday in an industrial accident at a GlaxoSmithKline (GSK) plant.
Read More